In an orthotopic mouse model of ovarian cancer the oncogene EphA2 could be silenced after three weeks of treatment with EphA2-targeting siRNA-DOPC and the tumor growth was reduced [12]. The gene discussed is EPHA2; the disease is ovarian cancer.